Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 1159981-95-9 | MDL No. : | MFCD11042744 |
Formula : | C6H4BrN3 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | DIYTVASYDOBYQA-UHFFFAOYSA-N |
M.W : | 198.02 | Pubchem ID : | 45480508 |
Synonyms : |
|
Num. heavy atoms : | 10 |
Num. arom. heavy atoms : | 9 |
Fraction Csp3 : | 0.0 |
Num. rotatable bonds : | 0 |
Num. H-bond acceptors : | 2.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 40.69 |
TPSA : | 30.19 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.55 cm/s |
Log Po/w (iLOGP) : | 1.64 |
Log Po/w (XLOGP3) : | 1.35 |
Log Po/w (WLOGP) : | 1.49 |
Log Po/w (MLOGP) : | 1.35 |
Log Po/w (SILICOS-IT) : | 1.2 |
Consensus Log Po/w : | 1.41 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -2.58 |
Solubility : | 0.516 mg/ml ; 0.0026 mol/l |
Class : | Soluble |
Log S (Ali) : | -1.59 |
Solubility : | 5.14 mg/ml ; 0.0259 mol/l |
Class : | Very soluble |
Log S (SILICOS-IT) : | -2.57 |
Solubility : | 0.533 mg/ml ; 0.00269 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 2.06 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P280-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H332-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
[ 705263-10-1 ]
6-Bromopyrazolo[1,5-a]pyrimidine
Similarity: 0.80
[ 55405-67-9 ]
3-Bromopyrazolo[1,5-a]pyrimidine
Similarity: 0.78
[ 1211578-31-2 ]
6-Bromo-3-methylpyrazolo[1,5-a]pyrimidine
Similarity: 0.77
[ 1436686-17-7 ]
Ethyl 5-bromopyrazolo[1,5-a]pyrimidine-3-carboxylate
Similarity: 0.69
[ 934560-92-6 ]
6-Bromo-1H-pyrazolo[3,4-b]pyridine
Similarity: 0.69
[ 705263-10-1 ]
6-Bromopyrazolo[1,5-a]pyrimidine
Similarity: 0.80
[ 55405-67-9 ]
3-Bromopyrazolo[1,5-a]pyrimidine
Similarity: 0.78
[ 1211578-31-2 ]
6-Bromo-3-methylpyrazolo[1,5-a]pyrimidine
Similarity: 0.77
[ 232600-93-0 ]
3-Aminopyrazolo[1,5-a]pyrimidine
Similarity: 0.74